CLINICALLY SIGNIFICANT LONG-TERM MAINTENANCE TREATMENT WITH OLAPARIB IN PATIENTS WITH PLATINUM-SENSITIVE RELAPSED SEROUS OVARIAN CANCER (PSR SOC)

被引：0
|
作者：
Friedlander, M. [1 ]
Gourley, C. [2 ]
Matulonis, U. [3 ]
Shirinkin, V. [4 ]
Selle, F. [5 ]
Scott, C. [6 ]
Safra, T. [7 ,8 ,9 ]
Fielding, A. [10 ]
Rowe, P. [10 ]
Ledermann, J. A. [11 ]
机构：
[1] Univ New South Wales, Clin Sch, Dept Med Oncol, Prince Wales Hosp, Randwick, NSW, Australia
[2] Univ Edinburgh, Canc Res UK Ctr, MRC IGMM, Med Oncol, Edinburgh, Midlothian, Scotland
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] State Inst Healthcare, Orenburg Reg Clin Oncol Dispensary, Orenburg, Russia
[5] Hosp Tenon, Serv Oncol Med, Paris, France
[6] Royal Melbourne Hosp, Med Oncol, Parkville, Vic, Australia
[7] Tel Aviv Sourasky Medicaly Ctr, Tel Aviv, Israel
[8] Tel Aviv Univ, Dept Oncol, Tel Aviv, Israel
[9] Sackler Sch Med, Tel Aviv, Israel
[10] AstraZeneca, Oncol Global Med Dev, Macclesfield, Cheshire, England
[11] UCL, Dept Oncol, UCL Canc Inst, London, England
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-1494
引用
收藏
页码：1942 / 1943
页数：2
相关论文
共 50 条
  • [1] CLINICALLY SIGNIFICANT LONG-TERM MAINTENANCE TREATMENT WITH OLAPARIB IN PATIENTS WITH PLATINUM-SENSITIVE RELAPSED SEROUS OVARIAN CANCER (PSR SOC)
    Friedlander, M.
    Gourlety, C.
    Matulonis, U.
    Shirinkin, V.
    Selle, F.
    Scott, C.
    Safra, T.
    Fielding, A.
    Rowe, P.
    Ledermann, J. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 13 - 13
  • [2] Clinically significant long-term maintenance treatment with olaparib in patients (pts) with platinum-sensitive relapsed serous ovarian cancer (PSR SOC).
    Gourley, Charlie
    Friedlander, Michael
    Matulonis, Ursula A.
    Shirinkin, Vadim
    Selle, Frederic
    Scott, Clare L.
    Safra, Tamar
    Fielding, Anitra
    Rowe, Philip
    Ledermann, Jonathan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer (SOC) and a BRCA mutation (BRCAm)
    Ledermann, Jonathan A.
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon J. S.
    Scott, Clare L.
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Fielding, Anitra
    Macpherson, Euan
    Dougherty, Brian
    Juergensmeier, Juliane M.
    Orr, Maria
    Matulonis, Ursula
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
    Ledermann, Jonathan A.
    Pujade-Lauraine, Eric
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [5] Frequency, severity and timing of common adverse events (AEs) with maintenance olaparib in patients (pts) with platinum-sensitive relapsed serous ovarian cancer (PSR SOC).
    Matulonis, Ursula
    Friedlander, Michael
    Du Bois, Andreas
    Gourley, Charlie
    Vergote, Ignace
    Rustin, Gordon J. S.
    Scott, Clare L.
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Fielding, Anitra
    McMurtry, Emma
    Spencer, Stuart
    Mann, Helen
    Parry, David
    Ledermann, Jonathan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
    Ledermann, Jonathan
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Macpherson, Euan
    Watkins, Claire
    Carmichael, James
    Matulonis, Ursula
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15): : 1382 - 1392
  • [7] Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer
    Jonathan A Ledermann
    Philipp Harter
    Charlie Gourley
    Michael Friedlander
    Ignace Vergote
    Gordon Rustin
    Clare Scott
    Werner Meier
    Ronnie Shapira-Frommer
    Tamar Safra
    Daniela Matei
    Anitra Fielding
    Bryan Bennett
    David Parry
    Stuart Spencer
    Helen Mann
    Ursula Matulonis
    British Journal of Cancer, 2016, 115 : 1313 - 1320
  • [8] Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer
    Ledermann, Jonathan A.
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Fielding, Anitra
    Bennett, Bryan
    Parry, David
    Spencer, Stuart
    Mann, Helen
    Matulonis, Ursula
    BRITISH JOURNAL OF CANCER, 2016, 115 (11) : 1313 - 1320
  • [9] Analysis of candidate homologous repair deficiency genes in a clinical trial of olaparib in patients (pts) with platinum-sensitive, relapsed serous ovarian cancer (PSR SOC).
    Dougherty, Brian
    Ledermann, Jonathan A.
    Lai, Zhongwu
    Robertson, Jane D.
    Ho, Tony
    Hodgson, Darren R.
    O'Connor, Mark J.
    Fielding, Anitra
    Hawryluk, Matthew J.
    Brennan, Tim
    Yelensky, Roman
    Sun, James
    Barrett, J. Carl
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC).
    Ledermann, J. A.
    Harter, P.
    Gourley, C.
    Friedlander, M.
    Vergote, I. B.
    Rustin, G. J. S.
    Scott, C.
    Meier, W.
    Shapira-Frommer, R.
    Safra, T.
    Matei, D.
    Macpherson, E.
    Watkins, C.
    Carmichael, J.
    Matulonis, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345